vs

Side-by-side financial comparison of Guardian Pharmacy Services, Inc. (GRDN) and PROCORE TECHNOLOGIES, INC. (PCOR). Click either name above to swap in a different company.

Guardian Pharmacy Services, Inc. is the larger business by last-quarter revenue ($397.6M vs $349.1M, roughly 1.1× PROCORE TECHNOLOGIES, INC.). Guardian Pharmacy Services, Inc. runs the higher net margin — 5.3% vs -10.8%, a 16.0% gap on every dollar of revenue.

CVS Pharmacy Inc. is an American retail corporation. A subsidiary of CVS Health, it is headquartered in Woonsocket, Rhode Island. Originally named the Consumer Value Stores, it was founded in Lowell, Massachusetts, in 1963.

Procore Technologies is an American construction management software as a service company founded in 2002, with headquarters in Carpinteria, California. Procore hosts a platform to connect those involved in the construction industry on a global platform. The software allows for the creation of simplified workflows and displays a consolidated view of construction products that includes the tracking of tasks, management of project workflows, and scheduling.

GRDN vs PCOR — Head-to-Head

Bigger by revenue
GRDN
GRDN
1.1× larger
GRDN
$397.6M
$349.1M
PCOR
Higher net margin
GRDN
GRDN
16.0% more per $
GRDN
5.3%
-10.8%
PCOR

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
GRDN
GRDN
PCOR
PCOR
Revenue
$397.6M
$349.1M
Net Profit
$20.9M
$-37.6M
Gross Margin
21.5%
80.1%
Operating Margin
7.7%
-12.3%
Net Margin
5.3%
-10.8%
Revenue YoY
15.6%
Net Profit YoY
39.6%
EPS (diluted)
$-0.25

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
GRDN
GRDN
PCOR
PCOR
Q4 25
$397.6M
$349.1M
Q3 25
$377.4M
$338.9M
Q2 25
$344.3M
$323.9M
Q1 25
$329.3M
$310.6M
Q4 24
$302.0M
Q3 24
$314.4M
$295.9M
Q2 24
$284.3M
Q1 24
$269.4M
Net Profit
GRDN
GRDN
PCOR
PCOR
Q4 25
$20.9M
$-37.6M
Q3 25
$9.8M
$-9.1M
Q2 25
$9.0M
$-21.1M
Q1 25
$9.4M
$-33.0M
Q4 24
$-62.3M
Q3 24
$-122.0M
$-26.4M
Q2 24
$-6.3M
Q1 24
$-11.0M
Gross Margin
GRDN
GRDN
PCOR
PCOR
Q4 25
21.5%
80.1%
Q3 25
19.8%
79.7%
Q2 25
19.8%
79.1%
Q1 25
19.5%
79.1%
Q4 24
81.2%
Q3 24
19.4%
81.4%
Q2 24
83.1%
Q1 24
83.0%
Operating Margin
GRDN
GRDN
PCOR
PCOR
Q4 25
7.7%
-12.3%
Q3 25
4.3%
-4.4%
Q2 25
3.7%
-9.3%
Q1 25
3.9%
-11.7%
Q4 24
-21.9%
Q3 24
-33.3%
-12.3%
Q2 24
-5.2%
Q1 24
-7.0%
Net Margin
GRDN
GRDN
PCOR
PCOR
Q4 25
5.3%
-10.8%
Q3 25
2.6%
-2.7%
Q2 25
2.6%
-6.5%
Q1 25
2.9%
-10.6%
Q4 24
-20.6%
Q3 24
-38.8%
-8.9%
Q2 24
-2.2%
Q1 24
-4.1%
EPS (diluted)
GRDN
GRDN
PCOR
PCOR
Q4 25
$-0.25
Q3 25
$-0.06
Q2 25
$-0.14
Q1 25
$-0.22
Q4 24
$-0.42
Q3 24
$-0.18
Q2 24
$-0.04
Q1 24
$-0.08

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
GRDN
GRDN
PCOR
PCOR
Cash + ST InvestmentsLiquidity on hand
$65.6M
$768.5M
Total DebtLower is stronger
$0
Stockholders' EquityBook value
$217.9M
$1.3B
Total Assets
$412.7M
$2.2B
Debt / EquityLower = less leverage
0.00×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
GRDN
GRDN
PCOR
PCOR
Q4 25
$65.6M
$768.5M
Q3 25
$36.5M
$684.0M
Q2 25
$18.8M
$620.9M
Q1 25
$14.0M
$566.7M
Q4 24
$775.4M
Q3 24
$37.2M
$756.9M
Q2 24
$735.4M
Q1 24
$744.6M
Total Debt
GRDN
GRDN
PCOR
PCOR
Q4 25
$0
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
$34.3M
Q2 24
Q1 24
Stockholders' Equity
GRDN
GRDN
PCOR
PCOR
Q4 25
$217.9M
$1.3B
Q3 25
$195.5M
$1.2B
Q2 25
$179.7M
$1.2B
Q1 25
$163.2M
$1.2B
Q4 24
$1.3B
Q3 24
$133.9M
$1.3B
Q2 24
$1.3B
Q1 24
$1.2B
Total Assets
GRDN
GRDN
PCOR
PCOR
Q4 25
$412.7M
$2.2B
Q3 25
$390.0M
$2.1B
Q2 25
$356.3M
$2.0B
Q1 25
$334.0M
$1.9B
Q4 24
$2.1B
Q3 24
$348.0M
$2.0B
Q2 24
$2.0B
Q1 24
$1.9B
Debt / Equity
GRDN
GRDN
PCOR
PCOR
Q4 25
0.00×
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
0.26×
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
GRDN
GRDN
PCOR
PCOR
Operating Cash FlowLast quarter
$34.6M
$114.9M
Free Cash FlowOCF − Capex
$109.2M
FCF MarginFCF / Revenue
31.3%
Capex IntensityCapex / Revenue
1.6%
Cash ConversionOCF / Net Profit
1.65×
TTM Free Cash FlowTrailing 4 quarters
$282.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
GRDN
GRDN
PCOR
PCOR
Q4 25
$34.6M
$114.9M
Q3 25
$28.2M
$88.5M
Q2 25
$19.9M
$30.8M
Q1 25
$17.6M
$66.0M
Q4 24
$29.1M
Q3 24
$39.3M
Q2 24
$58.7M
Q1 24
$69.1M
Free Cash Flow
GRDN
GRDN
PCOR
PCOR
Q4 25
$109.2M
Q3 25
$24.2M
$83.1M
Q2 25
$27.9M
Q1 25
$62.0M
Q4 24
$17.4M
Q3 24
$35.7M
Q2 24
$56.8M
Q1 24
$67.1M
FCF Margin
GRDN
GRDN
PCOR
PCOR
Q4 25
31.3%
Q3 25
6.4%
24.5%
Q2 25
8.6%
Q1 25
20.0%
Q4 24
5.8%
Q3 24
12.1%
Q2 24
20.0%
Q1 24
24.9%
Capex Intensity
GRDN
GRDN
PCOR
PCOR
Q4 25
1.6%
Q3 25
1.1%
1.6%
Q2 25
0.9%
Q1 25
1.3%
Q4 24
3.9%
Q3 24
1.2%
Q2 24
0.7%
Q1 24
0.8%
Cash Conversion
GRDN
GRDN
PCOR
PCOR
Q4 25
1.65×
Q3 25
2.87×
Q2 25
2.21×
Q1 25
1.86×
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

GRDN
GRDN

Segment breakdown not available.

PCOR
PCOR

US$298.3M85%
Non Us$50.9M15%

Related Comparisons